- Abstract Number: 2283
Characterization of Second-Line Therapy After First Janus Kinase Inhibitor Use: Results from the CorEvitas RA Registry
- Abstract Number: 0337
Characterization of Statin Induced Myopathy in the Hospital Setting
- Abstract Number: 1161
Characterization of the Clinical Presentation of Idiopathic Inflammatory Myopathies According to the Profile of Specific Autoantibodies with Multiple Positivity
- Abstract Number: 1585
Characterization of the Fecal Metabolome in Early Systemic Sclerosis
- Abstract Number: 2502
Characterization of the Tissue Fibroblast Repertoire in IgG4-Related Ophthalmic Disease
- Abstract Number: 0079
Characterization of the Tissue Resident Memorial T Cells in Autoimmune Arthritis: A Comparative Study of Psoriatic Arthritis and Rheumatoid Arthritis
- Abstract Number: 1848
Characterization of Treg Phenotype, Function and Its Transcriptome Signatures in Treatment-naïve Rheumatoid Arthritis
- Abstract Number: 0197
Characterizing Diet and Neighborhood Resources in Patients with Systemic Lupus Erythematosus
- Abstract Number: 0517
Characterizing Infusion-Related Reactions in Patients with Rheumatoid Arthritis Treated with Biologic DMARDs: Observations from the KOBIO Registry
- Abstract Number: 1797
Characterizing Memory T Cell Subsets Associated with SLE Etiopathogenesis
- Abstract Number: 2380
Characterizing SLE Patients into Type 1 and Type 2 Disease States: Insights from a Single Lupus Cohort
- Abstract Number: 0962
Characterizing the Contribution of Myeloid Cells to Limited and Diffuse Cutaneous Systemic Sclerosis
- Abstract Number: 2540
Characterizing the Functional Role of Type I Interferons in Inflammatory Arthritis
- Abstract Number: 2415
Characterizing the Population with Suspected Lupus Nephritis in Care of a Community Rheumatology Network
- Abstract Number: 0646
Chart Audit of over 1,000 SLE Patients Reveals Biologic Treatment Choice Driven by Disease Manifestations
- « Previous Page
- 1
- …
- 34
- 35
- 36
- 37
- 38
- …
- 181
- Next Page »